Latest Breaking News On - Capital to conduit pharmaceuticals - Page 1 : comparemela.com

Early-stage technology investor Vela Technologies said in an update on Friday that its total assets, including cash, decreased by £0.64m or 9% during the December quarter, amounting to £6.18m.

James normandCapital to conduit pharmaceuticalsStreet capitalConduit pharmaceuticalsVela technologiesCategory allCategory market reportCategory company newsCategory news and announcementsCategory small caps newsCategory aim bulletinCategory tecnologiaCategory market pulseCategory sectorial commercial servicesMostread technology